|
November 30 1999
Lek successfully underwent regular FDA inspection
November 24 1999
Lek and Lendava community building a purification plant
October 18 1999
Lek's business performance in the first 9 months of 1999
September 10 1999
A joint venture in Slovenia between Sanofi-Synthélabo and Lek
September 08 1999
Slovene and Macedonian artists for a new hospital in Skopje
August 31 1999
Good business results at the half-year
July 09 1999
The 11th Annual General Meeting of Lek d.d.
June 04 1999
The Workers' Council approves the appointment of the new Workers' Director
May 21 1999
Lek ready for new challenges
April 22 1999
Lek Kozmetika opens in Moscow
April 22 1999
New Board of Management
April 16 1999
Lek sends humanitarian aid to the crisis area in the Balkans
April 13 1999
Lek - the most reputable Slovene company
April 02 1999
Lek signed an agreement on development of a transdermal therapeutical form
March 29 1999
A relief for those suffering from hay fever
March 18 1999
Lek is granted a license for further public sale of B-class preferred shares
March 10 1999
Lek co-operates with FDA
March 10 1999
The Women of Lek make a charitable donation
March 03 1999
Lek's Board of Management
March 01 1999
Lek sales and profit in 1998
February 22 1999
Lek opens a representative office in Lithuania
February 12 1999
Lek wins patent suit on amlodipine bezilate in Slovenia
February 05 1999
New Chairman of the Supervisory Board
February 04 1999
Meeting between Lek and Pliva
January 29 1999
Resignation of Chairman of the Supervisory Board
January 21 1999
Rating of the Year Award for the third time
January 20 1999
25 successful years of Lek in Slovakia
January 20 1999
Lek's latest success in the American OTC market
January 20 1999
Lek's sales in Poland amounted to more than US$37 million
January 20 1999
The Russian crisis and its impact on Lek's performance
January 11 1999
Lek the best Slovene Company according to BCE
 |
